News

Scientists reveal plan to target the cause of Alzheimer’s diseaseResearchers have developed a new way to target the toxic particles that destroy healthy brain cells in Alzheimer’s disease. This is the first time that a systematic method to go after the pathogens – the cause of Alzheimer’s disease - has been proposed - Michele VendruscoloAcademics a…

The Chemistry of Health building, a new facility dedicated to the use of chemical techniques to combat disease, in particular neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, was officially opened today in Cambridge. The building houses the Centre for Misfolding Diseases, a world-leading research facility focused on the mis…

A Cambridge startup has developed a low-cost next-generation wearable heart and cardiovascular function monitor which uses AI to diagnose heart rhythm and respiratory problems in real time.Cambridge Heartwear hopes to use its wireless monitor to improve detection of irregular and dangerous heart rhythms and reduce the impact of stroke and stroke-re…

Implantable Device Stops Seizures at the First Signs of an EpisodeA new device from researchers at the University of Cambridge, École Nationale Supérieure des Mines and French National Institute of Health and Medical Research (INSERM) in France can stop seizures at the first symptom. So far researchers have implanted the device in the brains of mic…

A team of researchers at the University of Cambridge has identified a protein complex that might explain why some cancer patients treated with the revolutionary new anti-cancer drugs known as PARP inhibitors develop resistance to their medication.As we improve our understanding of these DNA repair networks and how they interact, we should be able t…

A new institute at the University of Cambridge aims to revolutionise cancer care by using cutting edge analytics to maximize the use of big data sets collected from patients.Integrated cancer medicine offers the promise of turning the tsunami of data generated in medical practice into an extraordinarily powerful but practical tool for patient benef…

The Prince of Wales Global Sustainability Fellowship Programme represents a multi-million-pound commitment from the private sector to accelerate progress on UN Sustainable Development Goals.The Prince of Wales Global Sustainability Fellowship Programme will create a rich intellectual space for collaboration between researchers and industry as we se…

Morphogen-IX Ltd, a preclinical biotechnology company focused on the development of bone morphogenetic proteins for the treatment of pulmonary arterial hypertension (PAH), today announced the appointment of Professor Nick Morrell as CEO. Morrell co-founded the company in 2015 based on research from his lab at the University of Cambridge.The company…

An international team of researchers have developed a low-cost sensor made from semiconducting plastic that can be used to diagnose or monitor a wide range of health conditions, such as surgical complications or neurodegenerative diseases. This work opens up new directions in biosensing, where materials can be designed to interact with a specific m…

New MPhil in Biotechnology – interdisciplinary training and a pathway for physicists, engineers, mathematicians and computer scientists to get into the biological sciencesThe Department of Chemical Engineering and Biotechnology is launching a new MPhil in Biotechnology, now  recruiting the first cohort to start in October 2018.The programme (11 mon…

The long-sought dream of wearable and mobile devices that will interpret, replicate and influence people’s emotions and perceptions will soon be a reality thanks to a collaboration between the University and Nokia Bell Labs.Nokia Bell Labs is a founding partner of the new Centre for Mobile, Wearable Systems and Augmented Intelligence, to be based i…

An algorithm to monitor the joints of patients with arthritis, which could change the way that the severity of the condition is assessed, has been developed by a team of engineers, physicians and radiologists led by the University of Cambridge. Using this technique, we’ll hopefully be able to identify osteoarthritis earlier, and look at potential t…

Business Secretary Greg Clark today announced funding for a series of ambitious technology projects that will transform the way medicines are discovered, enabling the pharmaceutical industry to develop groundbreaking drugs faster, cheaper and better than ever before.Our partnership in the institute gives us access to, and a leading role in, develop…

For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and death, and can reduce side effects, finds new research.We are confident that this will mark the first steps towards a reduction of Herceptin treatment to six months in many women with HER2-positive brea…

Professor Lynn Gladden CBE, FRS, FREng has been selected to be the next Executive Chair of the Engineering and Physical Sciences Research Council (EPSRC), as announced today by Science Minister Sam Gyimah. She will take up the role in October, succeeding Professor Philip Nelson who will step down at the end of September.Professor Gladden is current…